Enzo settles Thermo Fisher patent dispute for $35m
Thermo Fisher Scientific has agreed a $35 million settlement with Enzo Biochem in a patent infringement fight in a Delaware federal court over a pair of DNA testing patents.
The lawsuit, one of 11 infringement claims that Enzo filed against Thermo, centres on US patent numbers 6,992,180 and 7,064,197, which cover specific nucleotides and nucleic acids used in the mapping of genes.
Four of the suits have now been resolved while seven are still pending. This case was filed in the US District Court for the District of Delaware.
The settlement does not influence a separate patent litigation filed in Connecticut that is on appeal at the US Court of Appeals for the Federal Circuit.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk